Safety profile of belimumab: Pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus

Daniel J. Wallace, S. Navarra, M. A. Petri, A. Gallacher, M. Thomas, R. Furie, R. A. Levy, R. F. Van Vollenhoven, S. Cooper, Z. J. Zhong, W. Freimuth, R. Cervera

Research output: Contribution to journal › Article › peer-review

83 Scopus citations

Fingerprint

Dive into the research topics of 'Safety profile of belimumab: Pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus'. Together they form a unique fingerprint.

Medicine & Life Sciences